Areti Tychala, Georgios Meletis, Eugenia Katsimpourlia, Ioanna Gkeka, Rodoula Dimitriadou, Eleni Sidiropoulou, & Lemonia Skoura. (2021). Evaluation of the QuantiFERON SARS-CoV-2 assay to assess cellular immunogenicity of the BNT162b2 mRNA COVID-19 vaccine in individuals with low and high humoral response. Taylor & Francis Group.
Chicago Style (17th ed.) CitationAreti Tychala, Georgios Meletis, Eugenia Katsimpourlia, Ioanna Gkeka, Rodoula Dimitriadou, Eleni Sidiropoulou, and Lemonia Skoura. Evaluation of the QuantiFERON SARS-CoV-2 Assay to Assess Cellular Immunogenicity of the BNT162b2 MRNA COVID-19 Vaccine in Individuals with Low and High Humoral Response. Taylor & Francis Group, 2021.
MLA (9th ed.) CitationAreti Tychala, et al. Evaluation of the QuantiFERON SARS-CoV-2 Assay to Assess Cellular Immunogenicity of the BNT162b2 MRNA COVID-19 Vaccine in Individuals with Low and High Humoral Response. Taylor & Francis Group, 2021.